Abdul Rahman Omar Selected Research

flavokawain B

2/2016	Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro.
7/2015	In vitro Toxicity and in vivo Immunomodulatory Effects of Flavokawain A and Flavokawain B in Balb/C Mice.
1/2015	In vivo antitumor and antimetastatic effects of flavokawain B in 4T1 breast cancer cell-challenged mice.
10/2013	The flavokawains: uprising medicinal chalcones.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abdul Rahman Omar Research Topics

Disease

27	Infections 03/2022 - 08/2009
26	Neoplasms (Cancer) 07/2021 - 01/2003
16	Influenza in Birds (Avian Flu) 11/2020 - 09/2007
9	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2014
8	Human Influenza (Influenza) 01/2019 - 06/2009
5	Hemorrhagic Septicemia (Haemorrhagic Septicemia) 07/2019 - 10/2013
4	Virus Diseases (Viral Diseases) 07/2021 - 01/2014
4	Inflammation (Inflammations) 10/2020 - 10/2013
2	Bronchitis 12/2020 - 01/2015
2	Necrosis 01/2020 - 02/2014
2	Liver Neoplasms (Liver Cancer) 04/2018 - 01/2013
2	Type 2 Diabetes Mellitus (MODY) 01/2017 - 02/2013
2	Obesity 01/2017 - 02/2013
2	Newcastle Disease 01/2016 - 09/2009
2	Neoplasm Metastasis (Metastasis) 01/2015 - 01/2011
2	Colorectal Neoplasms (Colorectal Cancer) 01/2012 - 01/2011
2	Tuberculosis (Tuberculoses) 12/2010 - 01/2009
1	Autoimmune Diseases (Autoimmune Disease) 07/2021
1	West Nile Fever 12/2020
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2020
1	Sudden Death 07/2019
1	Salmonella Infections (Salmonellosis) 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Skin Neoplasms (Skin Cancer) 01/2018
1	Insulin Resistance 01/2017

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 07/2021 - 08/2012
11	CytokinesIBA 01/2020 - 02/2012
9	DNA VaccinesIBA 12/2020 - 05/2010
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2007
6	Antiviral Agents (Antivirals)IBA 10/2020 - 06/2009
6	2,5-dichloro-4-bromophenol (B 2)IBA 07/2019 - 10/2013
6	Antineoplastic Agents (Antineoplastics)IBA 03/2019 - 01/2003
4	Messenger RNA (mRNA)IBA 10/2020 - 02/2014
4	Pharmaceutical PreparationsIBA 01/2019 - 01/2009
4	Hemagglutinins (Hemagglutinin)IBA 01/2017 - 07/2012
4	Peptides (Polypeptides)IBA 04/2016 - 06/2009
4	flavokawain BIBA 02/2016 - 10/2013
4	flavokawain AIBA 07/2015 - 10/2013
3	InterferonsIBA 03/2022 - 11/2013
3	RNA (Ribonucleic Acid)IBA 12/2020 - 01/2013
3	Interleukin-15 (Interleukin 15)IBA 08/2018 - 08/2012
3	ChemokinesIBA 01/2018 - 01/2014
3	LipopolysaccharidesIBA 03/2017 - 11/2015
3	Dextrans (Dextran)FDA Link 01/2016 - 01/2011
2	Interleukin-10 (Interleukin 10)IBA 03/2022 - 06/2016
2	InterleukinsIBA 03/2022 - 01/2020
2	ChitosanIBA 12/2020 - 01/2020
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 10/2020 - 01/2018
2	Neuraminidase (Sialidase)IBA 01/2020 - 12/2013
2	Biological ProductsIBA 01/2020 - 06/2016
2	Interleukin-12 (IL 12)IBA 01/2020 - 06/2016
2	AntibodiesIBA 01/2020 - 06/2009
2	Tamoxifen FDA LinkGeneric 01/2019 - 02/2014
2	Virulence Factors (Pathogenicity Factors)IBA 01/2019 - 03/2017
2	LigandsIBA 01/2019 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 08/2018 - 06/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 07/2005
2	damnacanthalIBA 09/2016 - 05/2014
2	SpermineIBA 01/2016 - 01/2011
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2014 - 01/2014
2	NucleoproteinsIBA 12/2013 - 01/2013
2	Interleukin-18 (Interleukin 18)IBA 12/2013 - 08/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 08/2012
2	SilverIBA 01/2013 - 07/2012
2	SYBR Green IIBA 09/2009 - 09/2007
2	Codon (Codons)IBA 04/2007 - 07/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 03/2022
1	Antihypertensive Agents (Antihypertensives)IBA 05/2021
1	Glycoproteins (Glycoprotein)IBA 12/2020
1	SaponinsIBA 12/2020
1	Virus-Like Particle VaccinesIBA 11/2020
1	Fluorouracil (Carac)FDA LinkGeneric 10/2020
1	AcidsIBA 10/2020
1	Growth Factor ReceptorsIBA 10/2020
1	Glutamine (L-Glutamine)FDA Link 05/2020
1	CurcuminIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 07/2019
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 07/2019
1	Erythropoietin FDA Link 01/2019
1	Drug CarriersIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	LipidsIBA 01/2019
1	NK-lysinIBA 10/2018
1	CaspasesIBA 04/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2018
1	Cell-Penetrating PeptidesIBA 01/2018
1	SeptinsIBA 09/2017
1	pro-phenoloxidaseIBA 01/2017
1	crustinIBA 01/2017
1	Superoxides (Superoxide)IBA 01/2017
1	Interferon Type IIBA 01/2017
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017
1	AmyloseIBA 01/2017
1	Superoxide DismutaseIBA 01/2017

Therapy/Procedure

8	Therapeutics 01/2017 - 01/2003
3	Drug Therapy (Chemotherapy) 10/2020 - 09/2016
2	Immunotherapy 04/2016 - 01/2011
1	Transplantation 07/2021